LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged attack on tough cancers
Disease control Not yet recruitingThis trial is testing a new combination treatment for people with advanced solid tumors that have a specific genetic feature called PTEN loss or low expression. About 180 participants will take a pill called CVL237 along with an immunotherapy injection called serplulimab. The mai…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 02:42 UTC
-
New hope for tough cancers: early trial tests promising drug combo
Disease control Not yet recruitingThis early-stage study is testing the safety and initial effectiveness of a new drug called BC3195 when given alongside an existing immunotherapy (pembrolizumab). It is for adults with advanced solid tumors, like certain lung, breast, and head/neck cancers, that have spread or ca…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Biocity Biopharmaceutics Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New drug duo targets Tough-to-Treat KRAS cancers
Disease control Not yet recruitingThis study is testing whether combining two experimental drugs, GH21 and D-1553, can help control advanced cancers that have a specific genetic change called KRAS G12C. It is for adults with lung cancer or other solid tumors who have already tried standard treatments and a previo…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: Suzhou Genhouse Bio Co., Ltd. • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC